David Southwell
Director/Board Member at ROCKET PHARMACEUTICALS, INC.
Net worth: 5 M $ as of 30/03/2024
Profile
David P.
Southwell is currently serving as an Independent Director at PTC Therapeutics, Inc., as well as an Independent Director at THL Credit Secured Floating Rate Debt Ltd.
He is also a Director at Panel Intelligence LLC, Rocket Pharmaceuticals Ltd., and Sensorium Therapeutics, Inc. In the past, he held positions such as President, Chief Executive Officer & Director at Inotek Pharmaceuticals Corp., President, Chief Executive Officer & Director at TScan Therapeutics, Inc., and Chairman at BioSphere Medical, Inc. He has also served as an Independent Director at First Eagle Alternative Capital BDC, Inc. and as a Director at inVentiv Health, Inc., Spero Therapeutics, Inc., and Human Genome Sciences, Inc. Additionally, he worked as a Vice President at Lehman Brothers, Inc. and as Chief Financial Officer & Executive Vice President at Sumitomo Pharma America, Inc. Mr. Southwell completed his undergraduate studies at Rice University and holds an MBA from the Tuck School of Business at Dartmouth.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/04/2024 | 114,784 ( 0.13% ) | 3 M $ | 30/03/2024 | |
TSCAN THERAPEUTICS, INC.
0.39% | 30/03/2023 | 171,569 ( 0.39% ) | 1 M $ | 30/03/2024 |
PTC THERAPEUTICS, INC.
0.02% | 14/02/2024 | 14,500 ( 0.02% ) | 421 805 $ | 30/03/2024 |
David Southwell active positions
| Companies | Position | Start |
|---|---|---|
| PTC THERAPEUTICS, INC. | Director/Board Member | 30/11/2005 |
| ROCKET PHARMACEUTICALS, INC. | Director/Board Member | 31/12/2017 |
THL Credit Secured Floating Rate Debt Ltd.
 THL Credit Secured Floating Rate Debt Ltd. Financial ConglomeratesFinance THL Credit Secured Floating Rate Debt, Ltd. operates as a closed-end management investment company. It is managed by THL Credit Advisors LLC, which provides the administrative services. The company intends to elect to be treated as a business development company. THL Credit Secured Floating Rate Debt was founded on June 26, 2013 and is headquartered in Boston, MA. | Director/Board Member | - |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Director/Board Member | 04/01/2018 |
Panel Intelligence LLC
 Panel Intelligence LLC Internet Software/ServicesTechnology Services Panel Intelligence LLC offers a powerful online health care and medical research platform providing clients greater strategic direction for investment decisions, product development, and marketing. The private company is based in Cambridge, MA. William J. Febbo has been the CEO of the company since 2009. Panel Intelligence was acquired by Panel Intelligence /Private Group/ from Merriman Holdings, Inc. on January 30, 2009 for $1.10 million. | Director/Board Member | 12/06/2009 |
Sensorium Therapeutics, Inc.
 Sensorium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sensorium Therapeutics, Inc. is a biotechnology company based in Massachusetts. Sensorium Therapeutics leverages cutting-edge chemistry, neuroscience, and machine learning to develop nature-inspired psychoactive medicines for mental health. The American company's groundbreaking biodynamic discovery platform™ rapidly identifies, reproduces, adapts, and enhances targeted molecules to deliver transformational benefits to patients around the world. The company completed a $30m series A financing in late 2023 led by Santé Ventures, with participation from Route 66 Ventures, CU Healthcare Innovation Fund, and others. The company was founded by Jerrold F. Rosenbaum, Jacob Hooker, Richard Simon, Alex Simon, and Stephen Haggarty. Richard Simon has been the CEO since incorporation. | Director/Board Member | 11/09/2023 |
Former positions of David Southwell
| Companies | Position | End |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Chief Executive Officer | 26/03/2023 |
| SPERO THERAPEUTICS, INC. | Director/Board Member | 31/03/2019 |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Chief Executive Officer | 31/12/2017 |
| ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of David Southwell
| Rice University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| PTC THERAPEUTICS, INC. | Health Technology |
| SPERO THERAPEUTICS, INC. | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Private companies | 13 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
BioSphere Medical, Inc.
 BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Health Technology |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
| MedPanel, Inc. | Technology Services |
First Eagle Alternative Capital BDC, Inc.
 First Eagle Alternative Capital BDC, Inc. Investment ManagersFinance First Eagle Alternative Capital BDC, Inc., a traded business development company invests in middle market companies located in the United States. The fund targets companies operating in a broad range of sector. It provides equity and debt financing for investment securities with a revenue of $25 - $500 million. | Finance |
THL Credit Secured Floating Rate Debt Ltd.
THL Credit Secured Floating Rate Debt Ltd. Financial ConglomeratesFinance THL Credit Secured Floating Rate Debt, Ltd. operates as a closed-end management investment company. It is managed by THL Credit Advisors LLC, which provides the administrative services. The company intends to elect to be treated as a business development company. THL Credit Secured Floating Rate Debt was founded on June 26, 2013 and is headquartered in Boston, MA. | Finance |
inVentiv Health, Inc.
 inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Commercial Services |
Bionevia Pharmaceuticals, Inc.
 Bionevia Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Bionevia Pharmaceuticals, Inc. operates as a chronic disease hospital. Timothy Joseph Barberich has been the CEO of the American company since 2008. | Health Services |
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Health Technology |
Sensorium Therapeutics, Inc.
Sensorium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sensorium Therapeutics, Inc. is a biotechnology company based in Massachusetts. Sensorium Therapeutics leverages cutting-edge chemistry, neuroscience, and machine learning to develop nature-inspired psychoactive medicines for mental health. The American company's groundbreaking biodynamic discovery platform™ rapidly identifies, reproduces, adapts, and enhances targeted molecules to deliver transformational benefits to patients around the world. The company completed a $30m series A financing in late 2023 led by Santé Ventures, with participation from Route 66 Ventures, CU Healthcare Innovation Fund, and others. The company was founded by Jerrold F. Rosenbaum, Jacob Hooker, Richard Simon, Alex Simon, and Stephen Haggarty. Richard Simon has been the CEO since incorporation. | Health Technology |
Panel Intelligence LLC
Panel Intelligence LLC Internet Software/ServicesTechnology Services Panel Intelligence LLC offers a powerful online health care and medical research platform providing clients greater strategic direction for investment decisions, product development, and marketing. The private company is based in Cambridge, MA. William J. Febbo has been the CEO of the company since 2009. Panel Intelligence was acquired by Panel Intelligence /Private Group/ from Merriman Holdings, Inc. on January 30, 2009 for $1.10 million. | Technology Services |
- Stock Market
- Insiders
- David Southwell
